Unicorn Capital Partners
VC Fund
Hong Kong, Hong Kong
Unicorn Capital Partners is a VC fund in Hong Kong focused on Software and Enterprise. Founded in 2015, Unicorn Capital Partners is a leading fund-of-funds platform that focuses on venture capital fund and direct investment opportunities in China and Asia. At Unicorn, we are committed to building enduring partnerships with the best-of-breed venture capital managers investing at the forefront of emerging technology and innovation.
- Total investments:
- 15
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Unicorn Capital Partners invests in
Stages Unicorn Capital Partners invests in
Countries Unicorn Capital Partners invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alice Chan
|
|||
Eric Chang
|
|||
|
Kah Fai Low
|
|||
Tommy Yip
|
|||
Investment Focus
Industry
- Software 2 (13%)
- Enterprise 2 (13%)
- Health Care 2 (13%)
- Biotechnology 2 (13%)
- Pharmaceutical 2 (13%)
Stage
- Series B 6 (40%)
- Series A 2 (13%)
- Series C 2 (13%)
- Funding Round 1 (7%)
- Venture - Series Unknown 1 (7%)
Country
- China 8 (53%)
- United States 2 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Alice Chan
Partner & COO
|
Partner & COO | Total investments: 0 | Find email | |
|
Eric Chang
Partner
|
Partner | Total investments: 1 | Find email | |
|
Kah Fai Low
Co-Founder & Managing Partner
|
Co-Founder & Managing Partner | Total investments: 0 | Find email | |
|
Tommy Yip
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
LTZ Therapeutics
|
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need. | $38M / Venture - Series Unknown / May 06, 2026 | |
|
LTZ Therapeutics
|
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need. | $38M / Series B / May 06, 2026 | |
|
LTZ Therapeutics
|
LTZ develops novel immunotherapies to treat patients that suffer from cancer and other diseases with an unmet clinical need. | $40M / Series A / Apr 24, 2025 | |
Zelos
|
Zelos is an AI-driven startup is the way in autonomous driving technology. Its primary focus is on developing software and hardware that is centered around AI. Zelos offers intra-city autonomous transportation technologies, infrastructure, and optimal business models. | $200M / Series B / Apr 15, 2025 | |
Weijian Technology
|
Weijian Technology is a building intelligent robotics product company for the construction industry through robots, IoT, and AI algorithms. | $16.8M / Series A / Aug 23, 2024 | |
|
Zelos
|
Zelos is an AI-driven startup is the way in autonomous driving technology. Its primary focus is on developing software and hardware that is centered around AI. Zelos offers intra-city autonomous transportation technologies, infrastructure, and optimal business models. | $100M / Series A / Feb 27, 2024 | |
ArriVent
|
ArriVent is dedicated to accelerating the global development of innovative biopharmaceutical products. | $155M / Series B / Dec 29, 2022 | |
Hunan Yiyi Pharmaceutical Technology
|
Hunan Yiyi Pharmaceutical Technology | Series B / Aug 31, 2022 | |
Instant Design
|
Instant Design is a developer of cloud design tools and team collaboration platform, which develops cloud prototyping tools. | Series B / Jun 01, 2022 | |
Js Designs
|
'xiaopiu', a product of Beijing Xueyun Ruichuang Technology Co., Ltd., is an online APP prototyping tool. You can enjoy a software-level smooth experience by opening a browser, cloud component library, interactive motion customization, and efficient and friendly operation. Your creativity is instantly presented. * Cloud resources,one-click reference: Users can refer to shared resources shared by others with one click, so that users can focus more on expressing their ideas and ideas, and avoid creating wheels repeatedly. * Quickly build interactive animation: After creating the state and modifying the component to the desired style, we will automatically generate the tween animation. The user can preview and adjust the animation at any time through the bottom timeline, which is quick and convenient. * Global architecture, free to master: multi-view panel lists all the pages of the project, users can quickly process and logically arrange the page, so that the entire project architecture is unobstructed. | Series B / Jun 01, 2022 | |
| See all 15 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Unicorn Capital Partners invest in?
Unicorn Capital Partners invests primarily in Software, Enterprise and Health Care startups, most often at Series B and Series A stage. Most of the 15 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Unicorn Capital Partners?
Public channels for Unicorn Capital Partners include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Unicorn Capital Partners?
The team at Unicorn Capital Partners includes Alice Chan (Partner & COO), Eric Chang (Partner) and Kah Fai Low (Co-Founder & Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
